z-logo
open-access-imgOpen Access
Mechanisms, Consequences, and Prevention of Coronary Graft Failure
Author(s) -
Mario Gaudino,
Charalambos Antoniades,
Umberto Benedetto,
Saswata Deb,
Antonino Di Franco,
Gabriele Di Giammarco,
Stephen E. Fremes,
David Glineur,
Juan B. Grau,
GuoWei He,
Daniele Marinelli,
Lucas B. Ohmes,
Carlo Patrono,
John D. Puskas,
Robert F. Tranbaugh,
Leonard N. Girardi,
David P. Taggart,
Marc Ruel,
Faisal G. Bakaeen
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.117.027597
Subject(s) - medicine , dyslipidemia , stenosis , vasospasm , cardiology , endothelial dysfunction , anastomosis , heart failure , thrombosis , diabetes mellitus , incidence (geometry) , coronary vessel , surgery , artery , intensive care medicine , disease , physics , subarachnoid hemorrhage , optics , endocrinology
Graft failure occurs in a sizeable proportion of coronary artery bypass conduits. We herein review relevant current evidence to give an overview of the incidence, pathophysiology, and clinical consequences of this multifactorial phenomenon. Thrombosis, endothelial dysfunction, vasospasm, and oxidative stress are different mechanisms associated with graft failure. Intrinsic morphological and functional features of the bypass conduits play a role in determining failure. Similarly, characteristics of the target coronary vessel, such as the severity of stenosis, the diameter, the extent of atherosclerotic burden, and previous endovascular interventions, are important determinants of graft outcome and must be taken into consideration at the time of surgery. Technical factors, such as the method used to harvest the conduits, the vasodilatory protocol, the storage solution, and the anastomotic technique, also play a major role in determining graft success. Furthermore, systemic atherosclerotic risk factors, such as age, sex, diabetes mellitus, hypertension, and dyslipidemia, have been variably associated with graft failure. The failure of a coronary graft is not always correlated with adverse clinical events, which vary according to the type, location, and reason for failed graft. Intraoperative flow verification and secondary prevention using antiplatelet and lipid-lowering agents can help reducing the incidence of graft failure.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom